Pfizer and BioNTech vaccine protect over 95% against COVID-19: The Lancet


The hope that all of this will end grows day by day. In a study by the journal The lancet it is shown that the vaccine Pfizer and BioNTech It is more than 95% effective against infections, hospitalizations, and due to death COVID-19.

The research data was based on the Israeli vaccination campaign, as only this antidote was used in the country of the Middle East, which was approved in December 2020 by the relevant authorities for the emergency.

Pfizer and BioNTech vaccine protect over 95% against COVID-19: The Lancet
Pfizer and BioNTech vaccine protect over 95% against COVID-19: The Lancet

According to the magazine, “there has been a significant and sustained decrease in the incidence of infections SARS-CoV-2 In all age groups, the percentage of people vaccinated with two doses of vaccine began to increase, demonstrating the positive public health impact of a national vaccination schedule at the national level. ”

  • You Might Be Interested: The Pfizer Vaccine Is Approved In The United States For Children 12-15 Years Old

Image: Depositphotos.com

The results showed that the vaccine was effective in 94.1% for infections, 96.9% for hospitalizations, and 97% for death from the virus for people over 85 years of age.

On the other hand, in young people and adults between 16 and 44 years of age, the injection prevented infection in 96.1% and death in 100% of cases.

The study took into account vaccination dates between January 24th and April 3rd, 2021. By the last day the statistics were collected, 61% of the population of Israel had already received at least one dose of vaccine.

  • Learn more: One dose of Pfizer or AstraZeneca vaccine can slow the spread of COVID-19 in homes by 50%

Similar Posts